Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis

Cancer Research
Holly E MarinJeffrey M Peters

Abstract

There is considerable debate whether peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) ligands potentiate or suppress colon carcinogenesis. Whereas administration of a PPARbeta ligand causes increased small intestinal tumorigenesis in Apc(min/+) mice, PPARbeta-null (Pparb-/-) mice exhibit increased colon polyp multiplicity in colon cancer bioassays, suggesting that ligand activation of this receptor will inhibit colon carcinogenesis. This hypothesis was examined by treating wild-type (Pparb+/+) and Pparb-/- with azoxymethane, coupled with a highly specific PPARbeta ligand, GW0742. Ligand activation of PPARbeta in Pparb+/+ mice caused an increase in the expression of mRNA encoding adipocyte differentiation-related protein, fatty acid-binding protein, and cathepsin E. These findings are indicative of colonocyte differentiation, which was confirmed by immunohistochemical analysis. No PPARbeta-dependent differences in replicative DNA synthesis or expression of phosphatase and tensin homologue, phosphoinositide-dependent kinase, integrin-linked kinase, or phospho-Akt were detected in ligand-treated mouse colonic epithelial cells although increased apoptosis was found in GW0742-treated Pparb+/+ mice. Consistent w...Continue Reading

References

Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C R BolandY S Kim
Jul 27, 1999·Archives of Pathology & Laboratory Medicine·G De PetrisK Elenitoba-Johnson
Oct 14, 2000·Annual Review of Cell and Developmental Biology·J P Kraehenbuhl, M R Neutra
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·R A GuptaR N DuBois
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·B H ParkK W Kinzler
May 12, 2001·The Journal of Investigative Dermatology·M WestergaardK Kristiansen
Jun 9, 2001·The Journal of Biological Chemistry·R A GuptaR N DuBois
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yanhong ShiRonald M Evans
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Geoffrey D GirnunBruce M Spiegelman
Jun 5, 2003·Biochimica Et Biophysica Acta·Jeffrey M PetersFrank J Gonzalez
Mar 30, 2004·Nature Medicine·Fred S HarmanJeffrey M Peters
Apr 23, 2004·The Journal of Investigative Dermatology·Matthias SchmuthKenneth R Feingold
May 13, 2004·British Journal of Cancer·L C LawrieG I Murray
Jul 13, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kimihiko MatsusueFrank J Gonzalez
Oct 14, 2004·Oncogene·Karen R ReedAlan R Clarke
Feb 3, 2005·Genes & Development·Stavit DroriBruce M Spiegelman
Jul 16, 2005·Cell Death and Differentiation·D J KimJ M Peters
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chouhei SakakuraAkeo Hagiwara
Dec 28, 2005·Biochemical and Biophysical Research Communications·Cho S AungSarah J Roberts-Thomson

❮ Previous
Next ❯

Citations

Jan 13, 2010·Pflügers Archiv : European journal of physiology·Jean-François MichielsNicole Wagner
Feb 10, 2012·Nature Reviews. Cancer·Jeffrey M PetersFrank J Gonzalez
Sep 5, 2008·The Journal of Biological Chemistry·Brian M NecelaE Aubrey Thompson
Jul 3, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Brenda FaiolaRichard T Miller
Nov 10, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Curtis J OmiecinskiJeffrey M Peters
Nov 30, 2006·Current Opinion in Gastroenterology·Robert S ChapkinJoanne R Lupton
Sep 24, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jennifer M MonkRobert S Chapkin
Jun 28, 2008·PPAR Research·Keisuke TachibanaTakefumi Doi
Dec 2, 2008·PPAR Research·David Bishop-Bailey, Karen E Swales
Jun 21, 2008·American Journal of Respiratory Cell and Molecular Biology·Tetyana V PedchenkoPierre P Massion
Apr 6, 2007·Endocrine Journal·Sadao TakahashiJuro Sakai
Jan 25, 2013·The Oncologist·Cristina BosettiGiovanni Corrao
Aug 30, 2008·PPAR Research·Ambra Pozzi, Jorge H Capdevila
May 24, 2008·PPAR Research·Rolf MüllerSabine Müller-Brüsselbach
Jun 14, 2008·PPAR Research·Dingzhi Wang, Raymond N Dubois
Sep 26, 2008·PPAR Research·Rolf MüllerSabine Müller-Brüsselbach
Apr 4, 2007·Digestive Diseases and Sciences·Holly E HollingsheadJeffrey M Peters
Mar 12, 2010·Journal of Cancer Research and Clinical Oncology·Clemens RöhrlBrigitte Marian
Mar 14, 2009·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Mitsuru IshizukaKeiichi Kubota
Apr 3, 2012·Journal of Diabetes and Its Complications·M KhazaeiA R Fallahzadeh
Jul 21, 2007·The EMBO Journal·Sabine Müller-BrüsselbachRolf Müller
Nov 5, 2013·Life Sciences·Louise S Mackenzie, Lisa Lione
Jul 25, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·F BiscettiA Flex
Sep 19, 2014·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Stefan Z LutzHans-Ulrich Häring
Dec 23, 2008·Prostaglandins & Other Lipid Mediators·Mallika GhoshTimothy Hla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.